Shopping Cart
- Remove All
- Your shopping cart is currently empty
LSD1/HDAC6-IN-1 is an orally active dual inhibitor targeting lysine specific demethylase 1 (LSD1) and histone deacetylase 6 (HDAC6), demonstrating promising anti-tumor activity, particularly valuable for multiple myeloma (MM) research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $359 | Backorder | |
10 mg | $578 | Backorder | |
25 mg | $1,160 | Backorder |
Description | LSD1/HDAC6-IN-1 is an orally active dual inhibitor targeting lysine specific demethylase 1 (LSD1) and histone deacetylase 6 (HDAC6), demonstrating promising anti-tumor activity, particularly valuable for multiple myeloma (MM) research [1]. |
In vitro | LSD1/HDAC6-IN-1 exhibits exceptional efficacy across various multiple myeloma (MM) cell lines[1]. |
In vivo | LSD1/HDAC6-IN-1 demonstrates efficacy in the MM.1S xenograft model[1]. |
Alias | LSD1/HDAC6-IN-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.